- Home
- NXG vs RXST Comparison
NXG vs RXST Comparison
Compare NXG & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NXG | RXST |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.4M | 305.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | NXG | RXST |
|---|---|---|
| Price | $56.40 | $6.36 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $11.60 |
| AVG Volume (30 Days) | 42.1K | ★ 624.0K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 14.78% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $134,479,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $35.22 | $6.62 |
| 52 Week High | $56.90 | $27.13 |
Technical Indicators
Market Signals| Indicator | NXG | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 57.69 | 29.08 |
| Support Level | $46.24 | N/A |
| Resistance Level | N/A | $9.11 |
| Average True Range (ATR) | 1.47 | 0.41 |
| MACD | 0.15 | -0.06 |
| Stochastic Oscillator | 70.13 | 0.58 |
Price Performance
Historical ComparisonAbout NXG NXG NextGen Infrastructure Income Fund of Beneficial Interest
Cushing NextGen Infrastructure Income Fund is a closed-end management investment company. Its investment objective is to seek a high total return with an emphasis on current income. The fund invests at least 80% of its net assets in a portfolio of equity and debt securities of infrastructure companies, including energy infrastructure companies, industrial infrastructure companies, sustainable infrastructure companies and technology and communication infrastructure companies.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.